Integral Health Asset Management, LLC Amgen Inc Transaction History

Integral Health Asset Management, LLC

4 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 14, 2024	BUY	$262.75 - $319.31 $10.5 Million - $12.8 Million	40,000 New	40,000 $12.5 Million
Q3 2023 Nov 14, 2023	BUY	$218.65 - $271.46 $14.2 Million - $17.6 Million	65,000 New	65,000 $17.5 Million
Q3 2020 Nov 16, 2020	SELL	$234.65 - $260.95 $5.87 Million - $6.52 Million	-25,000 Closed	0 $0
Q2 2020 Aug 14, 2020	BUY	$197.81 - $242.74 $4.95 Million - $6.07 Million	25,000 New	25,000 $5.9 Million

3,123

409M

7.56M

7.2M

Ticker AMGN
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 534,931,008
Market Cap $146B
Description
Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...

Get notified when there are updates to the investment portfolio of Integral Health Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Integral Health Asset Management, LLC with notifications on news.